Presenter: Steve Miller, MD, MBA, Senior Vice President & Chief Medical Officer, Express Scripts
Steve Miller has served as Chief Medical Officer at Express Scripts since 2006, focusing on supporting government relations, leading the Pharmacy & Therapeutics committee, managing the Medical Affairs team and interfacing with client groups.
He received his medical degree from the University of Missouri-Kansas City, and he trained in the Pathology and Research fellowship at the University of Alabama at Birmingham.
He degrees in Internal Medicine which he recieved at the University of Colorado, Nephrology at Washington University, and did a cardiology research fellowship at University of California-San Francisco. Miller earned his MBA at Olin.
Dr. Steve Miller’s expertise represents years as a medical researcher, clinician and administrator, and spans numerous healthcare subjects. Since joining the company in 2005, Dr. Miller has represented Express Scripts as a presenter at nationwide conferences.
At Express Scripts, he is actively involved in developing their clinical programs and advancing the use of generic pharmaceuticals and specialty medications. Dr. Miller is a leader in the promotion of legislation to create a pathway at the U.S. Food and Drug Administration for the regulation of biogenerics and biosimilars.
Prior to joining Express Scripts, Dr. Miller was the vice president and chief medical officer at Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis.
6:15 – 7:00 pm Registration
7:00 – 9:00 pm Presentation and dinner
This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians. Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved. All members of the CME department have nothing to disclose. Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters. The presenters’ views do not represent the policy or position of Washington University School of Medicine. Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.